Literature DB >> 30063100

The neuropsychiatric phenotype in CACNA1A mutations: a retrospective single center study and review of the literature.

E Indelicato1, W Nachbauer1, E Karner1, A Eigentler1, M Wagner2, I Unterberger1, W Poewe1, M Delazer1, S Boesch1.   

Abstract

BACKGROUND AND
PURPOSE: CACNA1A encodes the α1 subunit of the neuronal calcium channel P/Q. CACNA1A mutations underlie three allelic disorders: familial hemiplegic migraine type 1 (FHM1), episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6). A clear-cut genotype-phenotype correlation is often lacking since clinical manifestations may overlap. Several case reports have described cognitive and behavioral features in CACNA1A disorders, but studies in larger case series are lacking.
METHODS: Genetically confirmed CACNA1A cases were retrieved from the database of the ataxia outpatient clinic of the Department of Neurology at Innsbruck Medical University. Clinical charts and neuropsychological test results were retrospectively analyzed. In addition, a review of the literature including only genetically confirmed cases was performed.
RESULTS: Forty-four CACNA1A cases were identified in our database. Delayed psychomotor milestones and poor school performance were described in seven (four FHM1, three EA2) and eight (three FHM1, five EA2) patients, respectively. Psychiatric comorbidities were diagnosed in eight patients (two FHM1, six EA2). Neuropsychological testing was available for 23 patients (11 FHM1, 10 EA2, two SCA6). Various cognitive deficits were documented in 21 cases (all patients except one SCA6). Impairments were predominantly seen in figural memory, visuoconstructive abilities and verbal fluency. In the literature, an early psychomotor delay is described in several children with EA2 and FHM1, whilst reports of cognitive and psychiatric findings from adult cases are scarce.
CONCLUSIONS: Neuropsychiatric manifestations are common in episodic CACNA1A disorders. In the case of otherwise unexplained developmental delay and a positive family history, CACNA1A mutations should be considered in the differential diagnosis.
© 2018 EAN.

Entities:  

Keywords:  zzm321990CACNA1Azzm321990; developmental delay; episodic ataxia type 2; familial hemiplegic migraine type 1; neuropsychological testing

Mesh:

Substances:

Year:  2018        PMID: 30063100     DOI: 10.1111/ene.13765

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  15 in total

1.  Calcium Channel Splice Variants and Their Effects in Brain and Cardiovascular Function.

Authors:  Sean Qing Zhang Yeow; Kelvin Wei Zhern Loh; Tuck Wah Soong
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Cerebellum and Emotion Memory.

Authors:  Melanie Mark; Johanna Pakusch; Thomas M Ernst; Dagmar Timmann
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

3.  The complexities of CACNA1A in clinical neurogenetics.

Authors:  Marina P Hommersom; Teije H van Prooije; Maartje Pennings; Meyke I Schouten; Hans van Bokhoven; Erik-Jan Kamsteeg; Bart P C van de Warrenburg
Journal:  J Neurol       Date:  2021-11-22       Impact factor: 6.682

4.  Whole-exome DNA sequencing in childhood anxiety disorders identifies rare de novo damaging coding variants.

Authors:  Emily Olfson; Eli R Lebowitz; Grace Hommel; Neha Pashankar; Wendy K Silverman; Thomas V Fernandez
Journal:  Depress Anxiety       Date:  2022-03-21       Impact factor: 8.128

Review 5.  The electrophysiological footprint of CACNA1A disorders.

Authors:  Elisabetta Indelicato; Iris Unterberger; Wolfgang Nachbauer; Andreas Eigentler; Matthias Amprosi; Fiona Zeiner; Edda Haberlandt; Manuela Kaml; Elke Gizewski; Sylvia Boesch
Journal:  J Neurol       Date:  2021-02-05       Impact factor: 4.849

6.  Biallelic variants in genes previously associated with dominant inheritance: CACNA1A, RET and SLC20A2.

Authors:  A Arteche-López; M I Álvarez-Mora; M T Sánchez Calvin; J M Lezana Rosales; C Palma Milla; M J Gómez Rodríguez; I Gomez Manjón; A Blázquez; A Juarez Rufián; P Ramos Gómez; O Sierra Tomillo; I Hidalgo Mayoral; R Pérez de la Fuente; I J Posada Rodríguez; L I González Granado; Miguel A Martin; J F Quesada-Espinosa; M Moreno-García
Journal:  Eur J Hum Genet       Date:  2021-07-15       Impact factor: 5.351

7.  Reversing frontal disinhibition rescues behavioural deficits in models of CACNA1A-associated neurodevelopment disorders.

Authors:  Alexis Lupien-Meilleur; Xiao Jiang; Mathieu Lachance; Vincent Taschereau-Dumouchel; Louise Gagnon; Catherine Vanasse; Jean-Claude Lacaille; Elsa Rossignol
Journal:  Mol Psychiatry       Date:  2021-06-14       Impact factor: 15.992

8.  A domain damage index to prioritizing the pathogenicity of missense variants.

Authors:  Hua-Chang Chen; Jing Wang; Qi Liu; Yu Shyr
Journal:  Hum Mutat       Date:  2021-08-15       Impact factor: 4.878

Review 9.  Paroxysmal Movement Disorders.

Authors:  Susan Harvey; Mary D King; Kathleen M Gorman
Journal:  Front Neurol       Date:  2021-06-11       Impact factor: 4.003

10.  Two distinct phenotypes, hemiplegic migraine and episodic Ataxia type 2, caused by a novel common CACNA1A variant.

Authors:  Rosaria Nardello; Giorgia Plicato; Giuseppe Donato Mangano; Elena Gennaro; Salvatore Mangano; Filippo Brighina; Vincenzo Raieli; Antonina Fontana
Journal:  BMC Neurol       Date:  2020-04-26       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.